AMNEAL PHARMACEUTICALS, INC. (AMRX) vs Kiniksa Pharmaceuticals International, plc (KNSA)
- AMNEAL PHARMACEUTICALS, INC. AMRX 19.18 −0.36%
- Kiniksa Pharmaceuticals International, plc KNSA 78.59 −1.69%
AMNEAL PHARMACEUTICALS, INC. and Kiniksa Pharmaceuticals International, plc are both Drug Manufacturers Specialty & Generic companies. AMNEAL PHARMACEUTICALS, INC. and Kiniksa Pharmaceuticals International, plc are of similar size ($6.2B and $6.2B). AMNEAL PHARMACEUTICALS, INC. trades at the lower P/E: 38.4× against 73.4×. Kiniksa Pharmaceuticals International, plc grew revenue faster over the last twelve months: 58.9% against 9.28%. Kiniksa Pharmaceuticals International, plc has the higher net margin (9.59% vs 5.05%) and the higher return on invested capital (48.9% vs 11.1%). Across the 20 metrics below, Kiniksa Pharmaceuticals International, plc leads on 14 and AMNEAL PHARMACEUTICALS, INC. on 6.
Valuation
Profitability
| Metric | AMRX | KNSA | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 39.32% | 89.82% | 53.94% |
| Operating margin | 14.56% | 11.92% | 0.00% |
| Net margin | 5.05% | 9.59% | 0.00% |
| Free cash flow margin | (0.37%) | 21.74% | 0.00% |
| Return on equity | (395.84%) | 14.04% | (0.40%) |
| Return on assets | 4.37% | 10.36% | (3.32%) |
| Return on invested capital | 11.05% | 48.87% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack